Another year, another B!
April 8, 2024 | Carbon Disclosure, Climate change, Pharma, Sustainability, healthcare comms
Louise Jones, Cuttsy+Cuttsy’s Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.
Yes, we’ve been awarded another B rating from Carbon Disclosure Project (CDP)! This is the second-highest rating available from CDP (which monitors environmental impact and risk management) and shows that we have been able to maintain our commitment to sustainability for the past 12 months, resulting in us being rewarded with another top rating!
The past year has been particularly momentous for us; we achieved net zero in both Scopes 1 and 2 (you’ll find more about the scope definitions here), which means we have just Scope 3 to conquer. Scope 3, which encompasses emissions resulting from the entire value chain, represents our last barrier to becoming a net zero company. And while achieving true net zero may be a challenge given the current technological landscape, our commitment is unwavering. We’re absolutely determined to get as close to zero as humanly possible!
Disclosing our progress through CDP is a crucial part of our bigger sustainability strategy, and with two years of experience under our belts, we’re embracing new changes in CDP’s submission structure as we head into 2024.
We’ve definitely encountered some roadblocks along the way. The main one being the complexity and time needed to accurately carbon report.
But there is light – after attending the CDP conference last year, we were given the welcome news of the questionnaire’s re-design, which hugely simplifies the reporting process. Firstly, by improving user-friendliness, and secondly (which is likely to be a very significant and far-reaching change), the merging of the climate, forestry, and water questionnaires. This promises to not only streamline the reporting process but for the likes of yours truly who is tasked with annual reporting, brings huge relief!
These changes are also likely to be big drivers in getting get more companies to participate in the scheme and disclose the details of their sustainability efforts. Because an accurate measurement of everyone’s impact is, after all, the only way to achieve true and effective global change. And CDP are clearly showing their commitment to this critical goal.
As we navigate through these improvements and challenges, Cuttsy+Cuttsy remains steadfast in its commitment to sustainability. And we look forward to making even greater strides in the coming years. Here’s to another year of progress and collective efforts towards a sustainable future.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
It’s time to stop calling adverse events ‘manageable’
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
The value: why localisation pays off across global trials
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
The solution: Good localisation doesn’t feel translated
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.
Healthcare information is becoming easier to access. Trust isn’t.
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.
Where translation falls short in practice
Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.
Where it all began – why we developed The Experience Gap
Learn how The Experience Gap was developed to help sponsors, CROs and site teams improve clinical trial participation by identifying friction points, enhancing patient experience, and driving better recruitment and...
Cuttsy+Cuttsy launches a practical roadmap to enhance clinical trial participant experience
Cuttsy+Cuttsy has launched The Experience Gap, a practical roadmap designed to help clinical trial teams improve participant engagement, support and retention across the full study journey.
Cuttsy+Cuttsy welcomes three new experts to the team
Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.
The gap between hype and reality, what patients really say about weight loss drugs
Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.